Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor.
Δ9-tetrahydrocannabinol (Δ9-THC), the main active ingredient of Cannabis sativa (marijuana), interacts with the human brain cannabinoid (CB1) receptor and mimics pharmacological effects of endocannabinoids (eCBs) like N-arachidonylethanolamide (AEA). Due to its flexible nature of AEA structure with...
Guardado en:
Autor principal: | Joong-Youn Shim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff484e4efd3848baa3d435ba32cb41ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cholesterol as a modulator of cannabinoid receptor CB2 signaling
por: Alexei Yeliseev, et al.
Publicado: (2021) -
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy
por: Fabio A. Iannotti, et al.
Publicado: (2018) -
Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration.
por: Martin Häring, et al.
Publicado: (2011) -
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
por: Marjolein Soethoudt, et al.
Publicado: (2017) -
Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations
por: Sang Won Jung, et al.
Publicado: (2018)